Medley, Inc. Lifts FY2027 Forecast on Path to Operating Profitability
Medley, Inc. (TSE:4480), Japan’s leading healthcare staffing and digital health platform operator, reported first-quarter results showing strong revenue momentum offset by continued operating losses as the company invests aggressively in growth initiatives. Management’s full-year guidance signals a decisive shift toward profitability, with operating profit expected to swing to JPY 2.95bn and net profit to nearly double.
| Metric | Q1 FY2026 | YoY Change |
|---|---|---|
| Revenue | JPY 10.2bn | +25.2% |
| Operating Profit | JPY -67M | — |
| Ordinary Income | JPY 61M | — |
| Net Profit | JPY -62M | — |
| Operating Margin | -0.7% | — |
| Equity Ratio | 29.9% | -6.0pp |
Business Overview
Medley, Inc. operates Japan’s largest healthcare staffing platform, “Job Medley,” which connects medical and care facilities with qualified personnel across nursing, care work, and allied health professions. The company also operates digital health services including telemedicine systems and medical information platforms. With 457,000 client facilities and 477,000 active job postings, Medley addresses Japan’s structural healthcare workforce shortage—a chronic challenge that underpins long-term demand for its matching services.
Q1 Analysis: Growth Investment Phase Continues
Revenue of JPY 10.2bn grew 25.2% year-over-year, driven by expansion in the core staffing business (segment revenue JPY 7.03bn, +27.6% YoY) and growing adoption of digital health platforms. However, the company posted an operating loss of JPY 67M, reflecting deliberate investment in customer acquisition, product development, and the newly expanded “Job Medley Academy” online training system.
The operating loss masks underlying cash generation strength. EBITDA reached JPY 631M, up 48.1% year-over-year, indicating that non-cash charges—primarily depreciation, amortization of goodwill, and stock-based compensation totaling approximately JPY 698M—account for the gap between operating performance and reported operating profit. This suggests the business is generating cash despite headline losses.
Ordinary income (keijo rieki, Japan’s recurring profit metric that includes non-operating items such as interest income) of JPY 61M reflects financial income offsetting the operating loss, a temporary cushion that will not persist as the company scales. The equity ratio declined to 29.9% from 35.9% in the prior period, as net assets fell JPY 1.74bn to JPY 13.06bn, signaling increased leverage to fund growth investments.
A critical seasonal factor: Japan’s healthcare sector concentrates hiring in April, coinciding with the fiscal year start and new graduate intake. Q1 (January–March) is structurally the weakest quarter for staffing platforms, meaning the JPY 10.2bn result understates the company’s underlying run rate. Management notes this explicitly in its disclosures.
Next Year Guidance
| Metric | FY2027 Forecast |
|---|---|
| Revenue | JPY 46.4bn |
| Operating Profit | JPY 2.95bn |
| Net Profit | JPY 1.8bn |
Assessment: Management’s full-year guidance is ambitious. Revenue is projected to grow 26.1% to JPY 46.4bn, while net profit is forecast to surge 84.5%, implying significant operating leverage and margin recovery. The operating profit forecast of JPY 2.95bn (6.4% margin) represents a dramatic turnaround from Q1’s -0.7% margin, reflecting management’s confidence that current investments will drive efficiency gains and scale benefits. The guidance assumes the company exits its investment phase by mid-year and achieves sustained profitability in H2.
What to Watch
Profitability inflection timing: The path from Q1’s JPY 67M operating loss to full-year JPY 2.95bn operating profit requires a sharp acceleration in H2. Investors should monitor quarterly results closely to confirm whether margin expansion materializes or whether guidance requires revision—a critical test of management’s execution capability.
Equity ratio stabilization: The 6.0-percentage-point decline in the equity ratio warrants attention. If leverage continues rising while profitability remains elusive, financial risk could increase. Management must demonstrate that growth investments translate to bottom-line returns within the guidance period.
Seasonal demand normalization: Q2 and Q3 results will reveal whether the April hiring surge drives the revenue and profit acceleration management projects. A weaker-than-expected spring hiring season would signal structural headwinds to the full-year forecast.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.